“Taiwan Clinical Trial Consortium of Cardiovascular Diseases (TCTC-CVD)” is a non-profit research alliance focusing on cardiovascular disease research and clinical trials. We have 2 major branches: one for lipid and atherosclerosis-associated, another for hypertension-associated cardiovascular diseases. The purpose of TCTC-CVD is to share the clinical data and research achievements. The vision of TCTC-CVD is to make Taiwan to be one of the leading countries for the international lipid, hypertension, and atherosclerosis--associated cardiovascular disease clinical trials and new drug application, which aims to provide the patients with newly available diagnostic or therapeutic methods in light of the up-to-date new diagnostic or therapeutic developments. The goal of TCTC-CVD is to share among all members the integrated clinical database, bio-specimen and biomarkers, and to initiate and perform researches or clinical trials. 


The major tasks of TCHC are (1) to serve as a platform sharing the clinical trial related data and information for cooperative and translational researches for new diagnostic tests, biomarkers, and novel treatment drugs or diagnostic tools for lipid, hypertension, and atherosclerosis-associated cardiovascular diseases; (2) to promote the international research collaboration, to hold the international symposiums and to provide the members with the information and opportunities for participating in the international clinical trials.

Contact Us
Chau-Chung Wu, M.D., Ph.D.

Department of Internal Medicine, National Taiwan University Hospital, and Institute of Medical Education and Bioethics, College of Medicine, National Taiwan University, Taipei, Taiwan
Tel: +886-2-23123456 ext 88560
Fax: +886-2-23947899
Address: No. 7, Chung-Shan S. Road, Taipei 100, Taiwan

Secretary: Su-Wen, Chen                
phone: +886-2-23123456 ext 88560        

Contact person: Ying-Chi, Chuo
phone: +886-2-23123456 ext 88560